Publicacions en col·laboració amb investigadors/es de Hospital Universitario Puerta de Hierro (23)

2024

  1. Increased incidence and mortality from Listeria monocytogenes infection in Spain

    International Journal of Infectious Diseases, Vol. 145

  2. Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients

    GigaByte, Vol. 2024

  3. Obelisks – Newly discovered virus-like particles

    AIDS Reviews

  4. Obesity and cardiovascular and renal disease. Consensus document of the Preventive Cardiology, Clinical Cardiology, and Heart Failure Associations of the Spanish Society of Cardiology

    REC: CardioClinics, Vol. 59, Núm. 3, pp. 212-224

  5. Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

    AIDS reviews, Vol. 25, Núm. 4, pp. 162-172

  6. Prospects for Controlling Hepatitis B Globally

    Pathogens, Vol. 13, Núm. 4

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

    Drug Design, Development and Therapy, Vol. 17, pp. 155-166

  3. Consensus document on palliative care in cardiorenal patients

    Frontiers in Cardiovascular Medicine, Vol. 10

  4. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  5. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  6. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  7. Susceptibility to hepatitis B virus infection in adults living in Spain

    Liver International, Vol. 43, Núm. 5, pp. 1015-1020

  8. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

  9. Viral hepatitis in persons living with HIV in the post-COVID era

    AIDS reviews, Vol. 25, Núm. 1, pp. 1-13

2022

  1. Is SARS-CoV-2 the only cause of long-COVID?

    AIDS Reviews, Vol. 24, Núm. 4, pp. 183-196

  2. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

    International Journal of Infectious Diseases, Vol. 122, pp. 970-975

  3. Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases

    Future Microbiology, Vol. 17, Núm. 11, pp. 887-897

2021

  1. Envisioning a hepatitis delta cure with new antivirals

    Future Microbiology, Vol. 16, Núm. 13, pp. 927-930

  2. Main differences between the first and second waves of COVID-19 in Madrid, Spain

    International Journal of Infectious Diseases, Vol. 105, pp. 374-376